Morgan Stanley »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Morgan Stanley

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-12-31 $14M 12M 1.10
2024-09-30 $18M 16M 1.13
2024-06-30 $7.9M 6.1M 1.29
2024-03-31 $9.5M 8.2M 1.17
2023-12-31 $10M 10M 1.01
2023-09-30 $11M 10M 1.12

More positions owned by Morgan Stanley

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Morgan Stanley

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Linden Advisors
Advent Capital Management
Calamos Advisors
Highbridge Capital Management
Tenor Capital Management
Davidson Kempner Capital Management
Bank Of Montreal
Lazard Asset Management
Magnetar Financial
State Street Corporation
Bank of America Corporation
Millennium Management
Point72 Asset Management
FMR

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1